Allurion Technologies (ALURW) EPS (Weighted Average and Diluted) (2022 - 2026)
Allurion Technologies (ALURW) reported EPS (Weighted Average and Diluted) of -$0.46 for Q1 2026, down 48.39% on a YoY basis from -$0.89 in Q1 2025, and down 21.05% quarter-over-quarter from -$0.38 in Q4 2025.
Allurion Technologies (ALURW) EPS (Weighted Average and Diluted) (2022 - 2026) Analysis & Trends
Allurion Technologies has reported EPS (Weighted Average and Diluted) for 5 years, with the latest figure at -$0.46 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) fell 48.39% year-over-year to -$0.46; the trailing twelve-month figure through Mar 2026 stood at -$3.65 (down 79.8% YoY), and the FY2025 full-year result was -$3.81, down 19.06% from the prior year.
- EPS (Weighted Average and Diluted) for Q1 2026 stood at -$0.46, down from -$0.38 in the prior quarter.
- The five-year high for EPS (Weighted Average and Diluted) was $3.4 in Q3 2024, with the low at -$36.72 in Q4 2022.
- Historically, EPS (Weighted Average and Diluted) has averaged -$6.48 across 5 years, with a median of -$1.05 in 2025.
- Annual changes were most pronounced in 2023 — EPS (Weighted Average and Diluted) plunged 2458.49% — and 2024, when it surged 125.07%.
- Allurion Technologies' EPS (Weighted Average and Diluted) stood at -$36.72 in 2022, then soared by 74.48% to -$9.37 in 2023, then soared by 91.68% to -$0.78 in 2024, then soared by 51.28% to -$0.38 in 2025, then slipped by 21.05% to -$0.46 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.46 (Q1 2026), -$0.38 (Q4 2025), and -$1.53 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 2.24 |
| 10 | Allurion Technologies | - | - | 1.23 Mn | -0.46 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.46 |
| Dec 31, 2025 | -0.38 |
| Sep 30, 2025 | -1.53 |
| Jun 30, 2025 | -1.28 |
| Mar 31, 2025 | -0.31 |
| Dec 31, 2024 | -0.78 |
| Sep 30, 2024 | 3.40 |
| Jun 30, 2024 | -4.34 |
| Mar 31, 2024 | 0.96 |
| Dec 31, 2023 | -9.37 |
| Sep 30, 2023 | -13.56 |
| Jun 30, 2023 | -20.95 |
| Mar 31, 2023 | -17.09 |
| Dec 31, 2022 | -36.72 |
| Sep 30, 2022 | -0.53 |
| Jun 30, 2022 | -0.82 |